media

Markets

Market Nav

ANNUAL RESULTS

You can view the annual results for the last 5 years.
Concord Drugs Ltd.
( in Crs.)

ParticularsMar 23
Net Sales/Income from operations52.08
Total Income From Operations52.08
  
EXPENDITURE 
Consumption of Raw Materials41.16
Increase/Decrease in Stocks-0.16
Employees Cost4.92
Depreciation1.63
Other Expenses1.58
Total Expenses49.13
  
P/L Before Other Inc. , Int., Excpt. Items & Tax2.95
Other Income0.01
P/L Before Interest, Excpt. Items & Tax2.96
Interest1.71
P/L Before Exceptional Items & Tax1.25
P/L Before Tax1.25
Tax0.26
P/L After Tax from Ordinary Activities0.99
Net Profit/Loss For the Period0.99
Net P/L After Minority Interest & Share Of Associates0.99
  
Equity Share Capital9.32
EPS Before Extra Ordinary * 
Basic EPS (Rs.)1.06
Diluted EPS (Rs.)1.06
EPS After Extra Ordinary * 
Basic EPS (Rs.) 1.06
Diluted EPS (Rs.) 1.06
  
PBITOE Margin (%)5.65
PBTE Margin (%)2.39
PBT Margin (%)2.39
PAT Margin (%)1.89
PAT After MI And SOA Margin (%)1.89
ParticularsMar 23
Net Sales/Income from operations52.08
Total Income From Operations52.08
  
EXPENDITURE 
Consumption of Raw Materials41.16
Increase/Decrease in Stocks-0.16
Employees Cost4.92
Depreciation1.63
Other Expenses1.58
Total Expenses49.13
P/L Before Other Inc. , Int., Excpt. Items & Tax2.95
Other Income0.01
P/L Before Interest, Excpt. Items & Tax2.96
Interest1.71
P/L Before Exceptional Items & Tax1.25
P/L Before Tax1.25
Tax0.26
P/L After Tax from Ordinary Activities0.99
Net Profit/Loss For the Period0.99
Net P/L After Minority Interest & Share Of Associates0.99
Equity Share Capital9.32
EPS Before Extra Ordinary * 
Basic EPS (Rs.)1.06
Diluted EPS (Rs.)1.06
EPS After Extra Ordinary * 
Basic EPS (Rs.) 1.06
Diluted EPS (Rs.) 1.06
PBITOE Margin (%)5.65
PBTE Margin (%)2.39
PBT Margin (%)2.39
PAT Margin (%)1.89
PAT After MI And SOA Margin (%)1.89